Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Selumetinib is used to treat type 1 neurofibromatosis (NF1) in pediatric patients aged 2 years and older who have symptomatic, inoperable plexiform neurofibromas (an orphan drug de···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：220
Selumetinib is used to treat patients with neurofibromatosis type 1 (NF1) with plexiform neurofibromas that cannot be surgically removed.What side effects may Selumetinib cause?Sel···【more】
Article source：Captain MedicineRelease date：2026-02-10Recommended：235
The dosage of this medicine is individualized. Please follow the doctor’s instructions or the information on the medicine label. The following is only the average adult dosage. Do ···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：303
Sparsentan is indicated for slowing the progression of renal function decline in patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease deterior···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：331
The dosage of sparsentan is individualized; please use it in accordance with your doctor’s instructions or the information on the drug label.What are the daily precautions for spar···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：298
Sparsentan is indicated for slowing the decline in renal function in adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.What Pre···【more】
Article source：Captain MedicineRelease date：2026-02-09Recommended：276
Belzutifan produced by Lucius Pharmaceuticals is a bioequivalent generic drug with the same mechanism of action as the marketed drug. It is indicated for the treatment of diseases ···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：205
The version of belzutifan produced by Lucius Pharmaceuticals is a more cost-effective generic drug, designed to provide renal cell carcinoma patients with the same active ingredien···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：238
Belzutifan is an oral targeted drug of the hypoxia-inducible factor-2α (HIF-2α) inhibitor class, mainly indicated for the treatment of various tumors associated with von Hippel-Lin···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：259
Belzutifan is a hypoxia-inducible factor (HIF) inhibitor. It exerts its effect by blocking a protein known as HIF-2α.Is Belzutifan associated with severe side effects?The severe si···【more】
Article source：Captain MedicineRelease date：2026-02-06Recommended：260
Doctors should conduct regular follow-ups to evaluate the efficacy of the medication, and adverse reactions may need to be monitored through blood and urine tests.Precautions for U···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：181
After administration, necessary therapeutic effects may occur, and adverse reactions may also be triggered. Not all adverse reactions will manifest. If any adverse reaction occurs,···【more】
Article source：Captain MedicineRelease date：2026-02-05Recommended：199
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
